Citation tools
"Interim results of a Phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with mCRPC post androgen signalling inhibition and 2 lines of taxane chemotherapy (LuPIN trial).." Journal of Nuclear Medicine
60.supplement 1
(2019):
465.
Web. 21 April. 2025.